Teva Pharmaceutical Industries Ltd TEVA
1 target with a reported result
Releases of the last 3 yearsThe numbers TEVA said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| Operating income (company-defined) Fiscal 2027 |
Given $700.00M release Nov 3, 2026
|
– | No standard number | |
The company's wordsTeva continued to transform and modernize its business through the Teva Transformation programs, which combined with innovative product growth potential, is expected to support the Company’s objective of achieving a 30% non-GAAP operating income margin and approximately $700 million of net savings, by 2027 including ~two-thirds expected to be realized in 2026. release Nov 3, 2026 | ||||
| Revenue Fiscal 2026 |
Given $16.50B to $16.85B release Jul 29, 2026
|
– | Not reported yet | |
The company's words2026 FinancialOutlook … Revenues 16.4 - 16.8 $16.5 - $16.85B release Jul 29, 2026 | ||||
| EBITDA (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $4.50B to $5.00B release May 8, 2024
|
– | No standard number | |
The company's wordsFull year 2024 business outlook reaffirmed: … Adjusted EBITDA of $4.5 - $5.0 billion release May 8, 2024 | ||||
| Free cash flow (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $1.70B to $2.00B release May 8, 2024
|
– | No standard number | |
The company's wordsFull year 2024 business outlook reaffirmed: … Free cash flow of $1.7 - $2.0 billion release May 8, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $2.20 to $2.50 release May 8, 2024
|
– | No standard number | |
The company's wordsFull year 2024 business outlook reaffirmed: … Non-GAAP diluted EPS of $2.20 - $2.50 release May 8, 2024 | ||||
| Revenue Fiscal 2024 (ended Dec 31, 2024) |
Given $15.70B to $16.30B release May 8, 2024
|
$16.54B 10-K filed 2025-02-05 |
Above the range | |
The company's wordsFull year 2024 business outlook reaffirmed: … Revenues of $15.7 - $16.3 billion release May 8, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2024-01-31), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TEVA/export.csv") into a cell.